GLP Watchdog

CoreAge Rx vs Hers

Hers has an open FDA warning letter dated September 9, 2025. CoreAge Rx has none. On compounded semaglutide injection, CoreAge Rx costs $1,440 less a year at standing rates: $79 a month against $199 a month at Hers.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

CoreAge Rx / Hers

Featured pick (affiliate partner)

CoreAge Rx logo

CoreAge Rx

9.0/10

Hers logo

Hers

6.8/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$79/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
48 states
All 50 states
Checked
Prices captured Record checked November 2026
Prices captured Record checked September 2026
Visit CoreAge Rx
Visit Hers

CoreAge Rx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hers pays us nothing. The scores are computed the same way for both and are shown as computed (CoreAge Rx 9.0, Hers 6.8). How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. CoreAge Rx has none.

  2. 02

    Hers names three pharmacies. CoreAge Rx names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, CoreAge Rx costs $1,440 less a year at standing rates: $79 a month against $199 a month at Hers.

  4. 04

    Only CoreAge Rx lists a price for compounded tirzepatide injection. Only Hers lists a price for brand-name tirzepatide pen.

  5. 05

    Hers covers two states CoreAge Rx does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

CoreAge Rx

Hers

Compounded semaglutide injection

$79/moLower

$948 a year

$199/mo

$2,388 a year

Compounded tirzepatide injection

$129/mo

$1,548 a year

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Price includes
Medication, clinician visits, shipping
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None
Refunds
Refund before provider approval, less a $50-$100 consult fee; final once sent to the pharmacy; none after 30 days
No refund guaranteed once the pharmacy has processed an order
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. CoreAge Rx: November 5, 2026. Hers: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for CoreAge Rx

9.0/10
Featured pick (affiliate partner)
  • No FDA warning letter on record
  • $1,440 a year less on compounded semaglutide injection
  • Sells compounded tirzepatide injection, which Hers does not price
  • Price includes clinician visits
  • Names no compounding pharmacy
Visit CoreAge Rx

The case for Hers

6.8/10
  • Sells brand-name tirzepatide pen, which CoreAge Rx does not price
  • Names its compounding pharmacy
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

Scores

CoreAge Rx 9.0 · Hers 6.8 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
7.0

Accessibility10%

9.7A
vs
B
10.0

Support10%

7.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

CoreAge Rx vs Hers: questions

Hers has an open FDA warning letter dated September 9, 2025. CoreAge Rx has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. CoreAge Rx names no compounding pharmacy in our record.
CoreAge Rx, by $1,440 a year at standing rates. CoreAge Rx: $79 a month, about $948 a year. Hers: $199 a month, about $2,388 a year.
CoreAge Rx states you can cancel at any time; refunds: refund before provider approval, less a $50-$100 consult fee; final once sent to the pharmacy; none after 30 days. Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order.
CoreAge Rx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hers pays us nothing. The scores are computed the same way for both and are shown as computed (CoreAge Rx 9.0, Hers 6.8).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks